FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/01/011199 [Registered on: 09/01/2018] Trial Registered Prospectively
Last Modified On: 08/01/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic
Preventive 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Mootrashmari Treatment With Palasha Kshara And Ashmarihara Kwatha  
Scientific Title of Study   Management Of Mootrashmari (Urolithiasis) With Palasha Kshara And Ashmarihara Kwatha - An Open Labelled Controlled Clinical Study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Monika Kumari 
Designation  MS 2 nd Year 
Affiliation  Institute for Post Graduate Training And Research Centre 
Address  OPD 01 6th floor Department of Shalya Tantra IPGT and RA GAU Jamnagar GUJARAT 361008 India
OPD 01 6th floor Department of Shalya Tantra IPGT and RA GAU Jamnagar GUJARAT 361008 India
Jamnagar
GUJARAT
361008
India 
Phone  9506817420  
Fax    
Email  dr.monika19@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr T S Dudhamal 
Designation  Associate Professor  
Affiliation  Institute for Post Graduate Training And Research Centre 
Address  6th floor Department of Shalya Tantra IPGT and RA GAU Jamnagar GUJARAT 361008 India
6th floor Department of Shalya Tantra IPGT and RA GAU Jamnagar GUJARAT 361008 India
Jamnagar
GUJARAT
361008
India 
Phone  9428671939  
Fax  02882676856  
Email  drtsdudhamal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr T S Dudhamal 
Designation  Associate Professor  
Affiliation  Institute for Post Graduate Training And Research Centre 
Address  6th floor Department of Shalya Tantra IPGT and RA GAU Jamnagar GUJARAT 361008 India
6th floor Department of Shalya Tantra IPGT and RA GAU Jamnagar GUJARAT 361008 India
Jamnagar
GUJARAT
361008
India 
Phone  9428671939  
Fax  02882676856  
Email  drtsdudhamal@gmail.com  
 
Source of Monetary or Material Support  
Institute For Post Graduate Training And Research In Ayurveda Gujarat Ayurved University Jamnagar Gujarat 361008 
 
Primary Sponsor  
Name  Institute for Post Graduate Training And Research Centre 
Address  Gujarat Ayurved University Jamnagar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Monika Kumari  PG Hospital IPGT and RA GAU Jamnagar Gujarat  OPD No 1 Department Of Shalya Tantra IPGT and RA Hospital Gujarat Ayurved University Jamnagar GUJARAT
Jamnagar
GUJARAT 
9506817420

dr.monika19@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patient diagnosed with Mootrashmari,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Palasha kshara with Ashmarihara kwath for 60 days  In Group A , patient will be given Palasha kshara capsule 500 mg TDS after meal and Ashmarihara kwatha 40 ml TDS after meal for 60 days  
Comparator Agent  Placebo Capsule with Water and Pathya Ahara  In Group B, Placebo Capsule of 500 mg TDS with more than 2 liters of water and Pathya Ahara for 60 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1) Patient having age between 18 to 70 years
2) Stone size upto 10 mm
3) Patients of ashmari with controlled HTN and Diabetes Mellitus
4) Renal and Ureteric stone will be included
 
 
ExclusionCriteria 
Details  1)Age below 18 years and above 70 years
2)Chronic Renal Failure
3)Gross Hydronephrosis
4)Acute Abdominal Pain
5)Cases which require Surgical Intervention
6)Severe Hematuria
7) Stone size more than 10 mm
8)Stone present in urinary bladder and urethera
9) Known cases of HIV, VDRL, Hepatitis, HTN ,Diabetes Mellitus,Cardiac disorders Malignancy ,TB 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Relief in sign and symptoms of Mootrashmari  60 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Improves quality of life of the person  Improves quality of life of the person 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/01/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not published yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
 This study comprises a Clinical Study to evaluate the effect of  Palasha kshara and Ashmarihara kwatha in the management of Mootrashmari w.s.r. Urolithiasis. The pathogenesis of Mootrashmari involve one important factor i.e. Kapha dosha dusti . Kshara having bhedana property and Ashmarihara kwath containing bhedana drug will not only reduce the stone size but also will maintain the Renal function. But as per claim of some of the Urologists that stone size less than 10 mm is excreted out without any kind of medication , so in another group Placebo capsule  and intake of plenty of water is advisable to patient . Thus this will not only validate the effetiveness of Ayurvedic drugs but will also prove its efficacy on Mootrashmari .

Procedure- 
In one group, for 60 days Palasha kshara capsule ( 500 mg ) TDS , Ashmarihara kwatha 40 ml TDS and pathya ahara is advised and  in another group Placebo capsule ( 500 mg ) TDS , drinking of  more than 2 litres of water and pathya ahara is advised and result will be noticed after 60 days through X Ray (KUB) and USG ( W/A and pelvis).

 
Close